Diabetes · Seattle area, WA
Diabetes studies in Seattle area, WA
24 recruiting studies have a site in the Seattle area. This page includes nearby cities such as Bellevue, Kirkland, Redmond, Renton.
24 recruiting studiesSource: ClinicalTrials.gov, refreshed October 26, 2026How we list studies
Studies
- RecruitingHealthy volunteersPhase 3
A Study of Aleniglipron in Adults With Obesity or Overweight and Type 2 Diabetes Mellitus (ACCOMPLISH-2)
Gasherbrum Bio, Inc., a wholly owned subsidiary of Structure Therapeutics
- Location
- Renton, WA + 55 other US sites
- Eligibility basics
- Ages 18–79
- Recruiting
Evaluation of MiniMed Next Generation Extended Wear Sensors and Algorithm in Patients With Type 1 and Type 2 Diabetes
Medtronic MiniMed, Inc.
- Location
- Renton, WA + 9 other US sites
- Eligibility basics
- Ages 2–80
- RecruitingPhase 3
A Research Study to See How Much CagriSema Lowers Blood Sugar and Body Weight Compared to Placebo in Children and Adolescents With Type 2 Diabetes
Novo Nordisk A/S
- Location
- Seattle, WA + 13 other US sites
- Eligibility basics
- Ages 10–18
- RecruitingPhase 3
Evaluation of Efficacy and Safety of Suzetrigine for Pain Associated With Diabetic Peripheral Neuropathy
Vertex Pharmaceuticals Incorporated
- Location
- Bellevue, WA + 57 other US sites
- Eligibility basics
- Ages 18–80
- RecruitingPhase 3
A Study to Test Whether Survodutide Helps People With Type 2 Diabetes Control Their Blood Sugar
Boehringer Ingelheim
- Location
- Redmond, WA + 56 other US sites
- Eligibility basics
- Ages 18+
- RecruitingPhase 3
A Study to Investigate Efficacy and Safety of Teplizumab Compared With Placebo in Participants 1 to 25 Years of Age With Stage 3 Type 1 Diabetes
Sanofi
- Location
- Seattle, WA + 33 other US sites
- Eligibility basics
- Ages 1–25
- RecruitingPhase 2
SAFety and Efficacy of Human Anti-thymocyte ImmunoGlobUlin SAB-142 ARresting Progression of Type 1 Diabetes
SAb Biotherapeutics, Inc.
- Location
- Seattle, WA + 20 other US sites
- Eligibility basics
- Ages 5–40
- RecruitingPhase 3
A Clinical Study to Evaluate the Effects of Enicepatide (RO7795068) in Participants With Obesity or Overweight and Type 2 Diabetes
Hoffmann-La Roche
- Location
- Redmond, WA + 44 other US sites
- Eligibility basics
- Ages 18+
- RecruitingPhase 2
A Study of LY3457263 Compared With Placebo in Participants With Type 2 Diabetes on a Stable Dose of Semaglutide or Tirzepatide
Eli Lilly and Company
- Location
- Redmond, WA + 24 other US sites
- Eligibility basics
- Ages 18–75
- RecruitingPhase 2
A Master Protocol Study (LY900028) of Multiple Intervention-Specific-Appendices (ISAs) in Participants With Chronic Pain
Eli Lilly and Company
- Location
- Bellevue, WA + 34 other US sites
- Eligibility basics
- Ages 18+
- RecruitingPhase 1/Phase 2
CNP-103 in Adolescent and Adult Subjects Ages 12-35 With Recently Diagnosed (Within 6 Months) Stage 3 Type 1 Diabetes (T1D)
COUR Pharmaceutical Development Company, Inc.
- Location
- Seattle, WA + 44 other US sites
- Eligibility basics
- Ages 12–35
- RecruitingPhase 3
A Study of Dulaglutide (LY2189265) 3.0 mg and 4.5 mg in Pediatric Participants With Type 2 Diabetes Mellitus (AWARD-PEDS PLUS)
Eli Lilly and Company
- Location
- Seattle, WA + 39 other US sites
- Eligibility basics
- Ages 10–17
- RecruitingPhase 2
A Chronic Pain Master Protocol (CPMP): A Study of LY4065967 in Participants With Diabetic Peripheral Neuropathic Pain
Eli Lilly and Company
- Location
- Bellevue, WA + 35 other US sites
- Eligibility basics
- Ages 18+
- RecruitingPhase 2
A Study of the Effect of ZT-01 on Night-time Hypoglycemia in Type 1 Diabetes
Zucara Therapeutics Inc.
- Location
- Seattle, WA + 36 other US sites
- Eligibility basics
- Ages 18–75
- Recruiting
ROME GS System Study
Senseonics, Inc.
- Location
- Renton, WA + 2 other US sites
- Eligibility basics
- Ages 18+
- Recruiting
Accuracy and Precision of the Continuous Glucose Monitoring System 'CareSens Air 3' in Adult Patients With T1DM
i-SENS, Inc.
- Location
- Renton, WA + 1 other US site
- Eligibility basics
- Ages 18–65
- RecruitingPhase 2
Pharmacokinetic and Early Efficacy of OPT101 in Patients With Type 1 Diabetes Mellitus
Op-T LLC
- Location
- Renton, WA + 4 other US sites
- Eligibility basics
- Ages 18–50
- Recruiting
Viome Nutritional Programs to Improve Clinical Outcomes for Metabolic Conditions
Viome
- Location
- Bothell, WA
- Eligibility basics
- Ages 25–75
- Recruiting
Efficacy of Viome's Precision Nutrition Program Towards Reducing HbA1c
Viome
- Location
- Bothell, WA
- Eligibility basics
- Ages 18+
- Recruiting
Efficacy of Viome's Precision Nutrition Program Towards Reducing HbA1c
Viome
- Location
- Bothell, WA
- Eligibility basics
- Ages 18+
- Recruiting
Study of Enhanced Programming Stimulation with the Enterra® Therapy System
Enterra Medical, Inc.
- Location
- Seattle, WA + 5 other US sites
- Eligibility basics
- Ages 18–70
- RecruitingHealthy volunteers
North American Mitochondrial Disease Consortium Patient Registry and Biorepository (NAMDC)
Columbia University
- Location
- Seattle, WA + 15 other US sites
- Eligibility basics
- Any age listed
- RecruitingHealthy volunteers
TrialNet Pathway to Prevention of T1D
University of South Florida
- Location
- Seattle, WA + 16 other US sites
- Eligibility basics
- Ages 2–45
- RecruitingHealthy volunteers
Puberty, Diabetes, and the Kidneys, When Eustress Becomes Distress (PANTHER Study)
Petter Bjornstad
- Location
- Seattle, WA + 1 other US site
- Eligibility basics
- Ages 8–14
Who these studies look for
Studies commonly set an HbA1c range, a diagnosis duration and a list of allowed or excluded medications. Some also recruit people without diabetes as a comparison group.
Matching a page like this one never means you qualify. Each research team decides eligibility at screening.